Summit Therapeutics Inc (NAS:SMMT)
$ 4.39 0.33 (8.13%) Market Cap: 3.08 Bil Enterprise Value: 3.03 Bil PE Ratio: 0 PB Ratio: 69.68 GF Score: 51/100

Summit Therapeutics Inc (SMMT) Stock Estimates Data

Summit Therapeutics Inc (SMMT) 12 Month Price Targets

Summit Therapeutics Inc (SMMT) Analyst Rating